Practical guideline on obesity care in patients with gastrointestinal and liver diseases

07/12/2023

Patients with chronic gastrointestinal disease such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux disease (GERD), pancreatitis, and chronic liver disease (CLD) often suffer from obesity because of coincidence (IBD, IBS, celiac disease) or related pathophysiology (GERD, pancreatitis and CLD). It is unclear if such patients need a particular diagnostic and treatment that differs from the needs of lean gastrointestinal patients. The present guideline addresses this question according to current knowledge and evidence.

Objective

The present practical guideline is intended for clinicians and practitioners in general medicine, gastroenterology, surgery and other obesity management, including dietitians and focuses on obesity care in patients with chronic gastrointestinal diseases.

Methods

The present practical guideline is the shortened version of a previously published scientific guideline developed according to the standard operating procedure for ESPEN guidelines. The content has been re-structured and transformed into flow-charts that allow a quick navigation through the text.

Results

In 100 recommendations (3XA,33xB,24×0,40xGPP, all with a consensus grade of 90% or more) care of gastrointestinal patients with obesity e including sarcopenic obesity e is addressed in a multidisciplinary way. A particular emphasis is on CLD, especially metabolic associated liver disease, since such diseases are closely related to obesity, whereas liver cirrhosis is rather associated with sarcopenic obesity. A special chapter is dedicated to obesity care in patients undergoing bariatric surgery. The guideline focuses on adults, not on children, for whom data are scarce. Whether some of the recommendations apply to children must be left to the judgment of the experienced pediatrician.

Conclusion

The present practical guideline offers in a condensed way evidence-based advice how to care for patients with chronic gastrointestinal diseases and concomitant obesity, an increasingly frequent constellation in clinical practice.

Published in the European Society for Clinical Nutrition and Metabolism.

 

Maybe you are interested

Clinical study of the effect of probiotic treatment with Lacteol on patients with IBS-D

RESEARCH The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant...
See more

The immune supporting properties of milk – Part 5: The immunoglobulins – Milk’s guided missiles

Introduction There is significant evidence suggesting that milk evolved to provide the newborn with defense against infections. From an evolutionary...
See more

The role of probiotics in children’s digestive system

The digestive system plays a fundamental role in the comprehensive development of children, directly affecting the ability to absorb nutrients,...
See more